By G HossainPosted on August 18, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs This is the third recent acquisition conducted by Denmark’s LEO Pharma in medical dermatology, a portfolio that marked 12% growth in the first half of the year. LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug Post navigation Rebounding biotech funds expected to spur CDMO growth within yearSandoz inks $322M Henlius deal for rights to as many as 10 biosimilars